LFCR logo

LFCR

Lifecore Biomedical Inc.

$7.64
+$0.27(+3.66%)
61
Overall
40
Value
83
Tech
--
Quality
Market Cap
$256.64M
Volume
276.55K
52W Range
$4.76 - $8.85
Target Price
$10.00

Company Overview

Mkt Cap$256.64MPrice$7.64
Volume276.55KChange+3.66%
P/E Ratio--Open$7.37
Revenue--Prev Close$7.37
Net Income--52W Range$4.76 - $8.85
Div YieldN/ATarget$10.00
Overall61Value40
Quality--Technical83

No chart data available

About Lifecore Biomedical Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Latest News

Craig-Hallum Sticks to Their Buy Rating for Lifecore Biomedical (LFCR)

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Lifecore Biomedical today. The company’s shares opened today at $6.94. According to Tip...

TipRanks Auto-Generated Intelligence Newsdesk19 days ago
ABCD
1SymbolPriceChangeVol
2LFCR$7.64+3.7%276.55K
3
4
5
6

Get Lifecore Biomedical Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.